Vera Frison

811 total citations
17 papers, 537 citations indexed

About

Vera Frison is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Vera Frison has authored 17 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Vera Frison's work include Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Management and Research (9 papers). Vera Frison is often cited by papers focused on Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (12 papers) and Diabetes Management and Research (9 papers). Vera Frison collaborates with scholars based in Italy, United States and Belgium. Vera Frison's co-authors include Angelo Avogaro, Gian Paolo Fadini, Saula de Kreutzenberg, Lisa Menegazzo, Elisa Boscaro, Carlo Agostini, Antonio Tiengo, Mattia Albiero, Natalino Simioni and Annunziata Lapolla and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

Vera Frison

17 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Frison Italy 10 393 238 128 107 63 17 537
Yuichi Terawaki Japan 10 299 0.8× 235 1.0× 83 0.6× 130 1.2× 36 0.6× 13 422
Yuriko Hamaguchi Japan 11 318 0.8× 322 1.4× 121 0.9× 144 1.3× 31 0.5× 20 495
Nina Wronkowitz Germany 7 385 1.0× 188 0.8× 297 2.3× 157 1.5× 46 0.7× 7 741
Wojciech Garczorz Poland 12 168 0.4× 173 0.7× 76 0.6× 95 0.9× 27 0.4× 28 411
Susumu Takagi Japan 6 190 0.5× 164 0.7× 56 0.4× 119 1.1× 27 0.4× 11 464
Jette Nowak Denmark 10 517 1.3× 324 1.4× 59 0.5× 178 1.7× 121 1.9× 20 675
Bea Waser Switzerland 7 257 0.7× 199 0.8× 207 1.6× 180 1.7× 54 0.9× 7 671
Stephanie Oldham United States 15 246 0.6× 281 1.2× 68 0.5× 164 1.5× 59 0.9× 26 889
M. Ahsan Siraj Canada 9 162 0.4× 149 0.6× 47 0.4× 56 0.5× 41 0.7× 12 411
Anne Charlotte Hegelund Denmark 9 525 1.3× 387 1.6× 79 0.6× 203 1.9× 121 1.9× 11 680

Countries citing papers authored by Vera Frison

Since Specialization
Citations

This map shows the geographic impact of Vera Frison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Frison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Frison more than expected).

Fields of papers citing papers by Vera Frison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Frison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Frison. The network helps show where Vera Frison may publish in the future.

Co-authorship network of co-authors of Vera Frison

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Frison. A scholar is included among the top collaborators of Vera Frison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Frison. Vera Frison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Morieri, Mario Luca, Vera Frison, M. Dambrosio, et al.. (2025). Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study. Diabetologia. 68(6). 1115–1125. 2 indexed citations
2.
Pintaudi, Basilio, Alessia Scatena, G. Piscitelli, et al.. (2021). Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study. Diabetes Research and Clinical Practice. 182. 109131–109131. 5 indexed citations
3.
Bonora, Benedetta Maria, Mauro Rigato, Vera Frison, et al.. (2021). Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care. Diabetes Research and Clinical Practice. 173. 108686–108686. 8 indexed citations
4.
Morieri, Mario Luca, Giovanni Targher, Annunziata Lapolla, et al.. (2021). Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study. Nutrition Metabolism and Cardiovascular Diseases. 31(12). 3474–3483. 9 indexed citations
5.
Pintaudi, Basilio, Alessia Scatena, G. Piscitelli, et al.. (2021). Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study. Cardiovascular Diabetology. 20(1). 59–59. 25 indexed citations
6.
Morieri, Mario Luca, Mauro Rigato, Vera Frison, et al.. (2020). Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies. Metabolism. 106. 154190–154190. 25 indexed citations
7.
Zenari, Luciano, Andrea Da Porto, Lorena De Moliner, et al.. (2020). Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira). Diabetes Therapy. 12(1). 197–209. 15 indexed citations
8.
Morieri, Mario Luca, Vera Frison, Mauro Rigato, et al.. (2020). Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients. The Journal of Clinical Endocrinology & Metabolism. 105(7). e2617–e2625. 18 indexed citations
9.
Fadini, Gian Paolo, Vera Frison, Mauro Rigato, et al.. (2019). Trend 2010–2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy. Acta Diabetologica. 57(3). 367–375. 21 indexed citations
10.
Morieri, Mario Luca, Mauro Rigato, Vera Frison, et al.. (2019). Fixed versus flexible combination of GLP‐1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study. Diabetes Obesity and Metabolism. 21(11). 2542–2552. 19 indexed citations
11.
Fadini, Gian Paolo, Vera Frison, Natalino Simioni, et al.. (2019). Changes in the Prescription of Glucose‐Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study. Journal of the American Heart Association. 8(14). e012244–e012244. 8 indexed citations
12.
Frison, Vera, Natalino Simioni, Sara Balzano, et al.. (2018). Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study. Diabetes Therapy. 9(6). 2201–2208. 9 indexed citations
13.
Simioni, Natalino, Alessio Filippi, Marco Scardapane, et al.. (2017). Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Therapy. 8(4). 941–946. 7 indexed citations
14.
Fadini, Gian Paolo, et al.. (2013). Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients. Acta Diabetologica. 50(6). 943–949. 42 indexed citations
15.
Genders, Amanda J., et al.. (2013). Endothelial Cells Actively Concentrate Insulin During its Transendothelial Transport. Microcirculation. 20(5). 434–439. 19 indexed citations
16.
Majumdar, S., et al.. (2011). Insulin entry into muscle involves a saturable process in the vascular endothelium. Diabetologia. 55(2). 450–456. 22 indexed citations
17.
Fadini, Gian Paolo, Elisa Boscaro, Mattia Albiero, et al.. (2010). The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes. Diabetes Care. 33(7). 1607–1609. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Terawaki Breakdown of academic impact, for papers by Yuriko Hamaguchi Breakdown of academic impact, for papers by Nina Wronkowitz Breakdown of academic impact, for papers by Wojciech Garczorz Breakdown of academic impact, for papers by Susumu Takagi Breakdown of academic impact, for papers by Jette Nowak Breakdown of academic impact, for papers by Bea Waser Breakdown of academic impact, for papers by Stephanie Oldham Breakdown of academic impact, for papers by M. Ahsan Siraj Breakdown of academic impact, for papers by Anne Charlotte Hegelund
Rankless by CCL
2026